Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for UEEC yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-18 | $0.06 | $0.06 | +8.51% | 0.6M |
| 05-19 | $0.07 | $0.06 | -11.68% | 0.2M |
| 05-20 | $0.06 | $0.05 | -0.91% | 0.4M |
| 05-21 | $0.06 | $0.05 | -1.23% | 0.0M |
| 05-22 | $0.06 | $0.05 | -3.12% | 0.0M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
UNITED HEALTH PRODUTS INC
Fundamentals not available for UEEC yet.
We pull from FMP, Finnhub, and Polygon — common gaps are very recent IPOs that haven't filed their first 10-Q, pink-sheet OTC tickers, and foreign filers without US-listed depth. The Financials tab reads SEC EDGAR directly and may still have data here.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-265.58K | $-2.26M | $-1.99M | $-1.76M |
Net Income | $-315.84K | $-2.67M | $-2.13M | $-315.19K |
EPS (Diluted) | $0.00 | $-0.01 | $-0.01 | $0.01 |
Total Assets | $248.82K | $316.70K | $94.31K | $81.54K |
Total Liabilities | $4.44M | $4.19M | $3.43M | $3.25M |
Cash & Equivalents | $1.03K | $65.25K | $18.38K | $225.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 258.69M | 258.69M | 258.69M | 257.13M |